highly significantp < 0.00001
Considering only INOCA patients, out of 38,987, only 195 (0.5%) experienced an adverse event related to ACh administration, while the incidence rate in the MINOCA population (34,319 pts) was 0.1%, configuring a highly significant difference among the two groups ( p < 0.00001). 4.